Mariana Peschard-Franco

Dr. Mariana Peschard-Franco

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
LELeticia Elizondo-Montemayor
Leticia Elizondo-Montemayor
AGAdrian Gonzalez-Gil
Adrian Gonzalez-Gil
OTOscar Tamez-Rivera
Oscar Tamez-Rivera
CTCarla Toledo-Salinas
Carla Toledo-Salinas
MPMariana Peschard-Franco
Mariana Peschard-Franco
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
Proinflammatory cytokines and the novel myokine irisin, a cleavage product of FNDC5, have been found to play a role in obesity and type 2 diabetes mellitus (T2DM). Irisin has been shown to increase browning of adipose tissue, thermogenesis, energy expenditure, and insulin sensitivity, yet its association with inflammatory markers is still limited. Circulating irisin has been found to be increased in obesity, while in adult subjects with T2DM decreased levels have been found. However, data establishing the association of circulating irisin in children and adolescents with T2DM has not been described in the literature. The objective of this study was to determine irisin plasma concentration and its association with metabolic and adiposity markers and with hs-CRP, a surrogate marker of inflammation used in clinical practice, in a pediatric population with T2DM. A cross-sample of 40 Mexican children and adolescents aged 7-17 were recruited, 20 diagnosed with T2DM and 20 healthy controls. Plasma irisin levels were found to be lower in the T2DM group compared with controls, which could be attributed to a reduced PGC-1α activity in muscle tissue with a consequent decrease in FNDC5 and irisin expression. Irisin concentration was found to be positively correlated with HDL-c, LDL-c, and total cholesterol, while negatively correlated with BMI, waist circumference, and triglycerides. However, after multiple regression analysis, only HDL-c correlation remained significant. hs-CRP was higher in the T2DM group and positively associated with adiposity markers, unfavorable lipid profile, insulin levels, and HOMA-IR, but no association with irisin was found. Given the favorable metabolic effects attributed to irisin, the low plasma levels found in children and adolescents with T2DM could exacerbate the inflammatory and metabolic imbalances and the intrinsic cardiovascular risk of this disease. We propose an “irisin-proinflammatory/anti-inflammatory axis” to explain the role of irisin as a metabolic regulator in obesity and T2DM.

Verified
Journal Article
Open access
PDF file
LELeticia Elizondo-Montemayor
Leticia Elizondo-Montemayor
GMGerardo Mendoza-Lara
Gerardo Mendoza-Lara
GGGustavo Gutierrez
Gustavo Gutierrez
MPMariana Peschard-Franco
Mariana Peschard-Franco
BNBianca Nieblas
Bianca Nieblas
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
Exercise-induced irisin, a recently discovered myokine, has been linked to insulin resistance, obesity, and other diseases in adults; however, information in children is scarce and contradictory. We analyzed the limited evidence of irisin’s effects in children and adolescents, and its association with body composition, exercise training, cardiovascular risk factors, and metabolic diseases, as well as the results of dietetic interventions. Both positive and negative correlations between irisin concentrations and body mass index, fat mass, fat-free mass, and other anthropometric parameters were found. Likewise, contradictory evidence was shown associating irisin plasma levels with cardiovascular and metabolic parameters such as glucose, insulin resistance, and cholesterol and other lipid and fatty acid plasma levels in healthy children, as well as in those with obesity and the metabolic syndrome. Gender, puberty, and hormonal differences were also examined. Furthermore, important contradictory findings according to the type and duration of exercise and of dietetic interventions in healthy and unhealthy subjects were demonstrated. In addition, correlations between mother–infant relations and circulating irisin were also identified. This review discusses the potential role of irisin in health and disease in the pediatric population.

5 August 2019 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
AGAdrian Gonzalez-Gil
Adrian Gonzalez-Gil
MPMariana Peschard-Franco
Mariana Peschard-Franco
ECElena C. Castillo
Elena C. Castillo
GGGustavo Gutierrez
Gustavo Gutierrez
VICTOR TREVINOVICTOR TREVINO
VICTOR TREVINO
LELeticia Elizondo-Montemayor
Leticia Elizondo-Montemayor
Adipokines and the myokine irisin, involved in mechanisms associated with obesity and metabolic syndrome (MS), are understudied in the pediatric population. To investigate the relationship between irisin, and leptin, resistin, adiponectin, adipsin, anthropometric and cardiovascular risk factors in Mexican children. A cross-sample of 126 Mexican children aged 6–12 years old were classified as normal weight (n = 46), obese (n = 40), and MS (n = 40) according to CDC’s and Cook’s age-modified criteria for obesity and MS. Anthropometric parameters and blood pressure were determined and percentiles calculated for age and gender. Irisin, leptin, adiponectin, adipsin, resistin, triglycerides, glucose, high-density lipoprotein cholesterol (HDL-c) levels, and physical activity were determined. Statistical tests for differences between groups, correlation, and multiple regression analyses were performed. Irisin plasma levels were significantly lower in the obese (6.08 [4.68–6.65]) and MS groups (6.46 [5.74–7.02]) compared with the normal-weight group (8.05 [7.24–8.94]) (p < 0.001). Irisin levels were not influenced by age or gender, but significant dispersion was observed in obese girls (95% CI median [2.29–6.30]). Leptin, resistin, and adipsin levels were significantly increased in the obese and MS groups. Lean-fat ratio was significantly higher in the NW group. Irisin correlated negatively with leptin (− 0.310), resistin (− 0.389), adipsin (− 0.362), BMI% (-0.472), WC% (− 0.453), BMI z-score (− 0.496), fat free mass (− 0.257), fat percentage (− 0.532), fat mass (− 0.515), triglycerides (− 0.291), the number of cardiometabolic risk factors (− 0.443) (p < 0.001); positively with lean-fat ratio (0.489) and HDL-c (0.328) (p < 0.001) and none with physical activity (p < 0.001). Following stepwise multiple linear regression analysis, the lean-fat ratio was the only determinant of irisin levels (B = 1.168, p < 0.001). Lean-fat ratio, more than the absolute amount of muscle or fat mass, as well as potential myokine–adipokine cross-talk mechanisms may explain the lower irisin levels in children with obesity and MS, through blunted compensatory responses interfering with tissue-dependent irisin secretion, contributing to a continuous deleterious effect cycle.

23 May 2018 in Cureus
Verified
Journal Article
Open access
PDF file
MGMiguel García-Grimshaw
Miguel García-Grimshaw
MPMariana Peschard-Franco
Mariana Peschard-Franco
FGFrancisco A Gutierrez-Manjarrez
Francisco A Gutierrez-Manjarrez
The occlusion of the artery of Percheron (AOP) is a rare condition that causes bilateral thalamic ischemic stroke with or without midbrain involvement. It happens as a result of an anatomical variant of the diencephalic irrigation, in which the thalamic paramedian arteries arise from a common trunk from the posterior cerebral artery (PCA), which generates a clinical syndrome characterized by bilateral vertical gaze palsy, memory impairment and hypersomnia. In this case, we report a 62-year-old woman admitted to the emergency room with altered mental status, mainly somnolence. On physical examination, she was somnolent, apathetic and with no motor deficit. Magnetic resonance imaging (MRI) of the brain demonstrated bilateral thalamic hyperintensities and midbrain involvement in diffusion-weighted imaging (DWI) and T2 sequences, suggesting occlusion of the AOP. Bilateral thalamic infarction due to this anatomical variant is an entity with a low prevalence, and its diagnosis can be delayed because of the wide spectrum of clinical signs.

1 August 2025 in The Neurohospitalist
Verified
Journal Article
Closed access
MPMariana Peschard-Franco
Mariana Peschard-Franco
EPEnrique Piña-Rosales
Enrique Piña-Rosales
AGAnwar García-Santos
Anwar García-Santos
Patients with acute psychiatric and cognitive symptoms can be challenging to evaluate, particularly in the context of renal or metabolic alterations. A 56-year-old woman initially presented with abdominal pain and vomiting, with no findings on physical examination. A severe chronic hypovolemic hypotonic hyponatremia was acknowledged in the lab work, leading to admission for sodium replacement and electrolyte imbalance correction. Two weeks later the patient developed altered mental status, agitation, psychosis and catatonia. This case highlights the diagnostic approach to patients with encephalopathy. Readers are guided through this stepwise approach, considering a wide range of differential diagnosis, including metabolic, infectious, autoimmune and paraneoplastic etiologies, with an extensive workup, ultimately arriving at the leading diagnosis.

5 January 2025 in The Neurohospitalist
Verified
Journal Article
Closed access
MPMariana Peschard-Franco
Mariana Peschard-Franco
A neurology resident reflects on a pivotal moment during the assessment of an elderly patient, when attention shifts unexpectedly to the patient’s caregiver, his wife. The resident quickly recognizes a neurological deficit that could potentially be treated. Sensing the urgency, the resident rushes her to the emergency department, where immediate treatment enables the caregiver to regain her ability to continue caring for her husband. This experience teaches the resident a profound lesson about the importance of vigilance not only toward primary patients but also toward those quietly supporting them. It highlights how timely intervention can preserve the connections that bind families, emphasizing the role of healthcare providers in maintaining these bonds.